Axsome醫療 AXSM 深 滬
等待開盤 09-09 09:30:00 美东时间
129.29
+4.120
+3.29%
華盛通- 最 高129.43
- 今 開124.26
- 成交量 75.15万股
- 最 低 124.1971
- 昨 收 125.17
- 總市值 63.66亿
- 52周最高 139.1299
- 市盈率 靜 --
- 換手率 1.53%
- 52周最低 75.56
- 委 比 -34.88%
- 總股本 4923.64万
- 歷史最高 139.1299
- 量 比 1.34
- 振 幅 4.18%
- 歷史最低 1.94
- 每 手 1
- 風險率 9.62%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Wells Fargo Assumes Axsome Therapeutics at Overweight, Announces Price Target of $163
Wells Fargo analyst Benjamin Burnett assumes Axsome Therapeutics (NASDAQ:AXSM) with a Overweight rating and announces Price Target of $163.
09-03 20:51
Axsome Therapeutics Receives Paragraph IV Certification Notice
The latest update is out from Axsome Therapeutics ( ($AXSM) ). On August 19, 20...
08-21 05:28
Tonix Pharma's Drug Gets FDA Nod For Chronic Pain Condition, First New Therapy In Over 15 Years
FDA approves Tonmya, a non-opioid fibromyalgia therapy from Tonix, with strong trial data and U.S. launch expected in late 2025.
08-18 21:45
Axsome Therapeutics shares are trading higher after the company reported better-than-expected Q2 financial results.
Axsome Therapeutics shares are trading higher after the company reported better...
08-04 20:33
Needham Reiterates Buy on Axsome Therapeutics, Maintains $150 Price Target
Needham analyst Ami Fadia reiterates Axsome Therapeutics (NASDAQ:AXSM) with a Buy and maintains $150 price target.
08-04 20:02
Axsome Therapeutics Reports Strong Q2 2025 Performance
An update from Axsome Therapeutics ( ($AXSM) ) is now available. On August 4, 2...
08-04 19:58
Axsome Therapeutics Q2 Adj. EPS $(0.47) Beats $(1.07) Estimate, Sales $150.04M Beat $140.33M Estimate
Axsome Therapeutics (NASDAQ:AXSM) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of $(1.07) by 56.2 percent. This is a 58.04 percent increase over losses of $(1.12) per share
08-04 19:02
Earnings Scheduled For August 4, 2025
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is likely to rep...
08-04 16:32
A Look at Axsome Therapeutics's Upcoming Earnings Report
Axsome Therapeutics (NASDAQ:AXSM) is preparing to release its quarterly earning...
08-02 01:04
Axsome Therapeutics Spotlights Broad Clinical Pipeline In Alzheimer's Agitation, MDD, Narcolepsy, And Fibromyalgia At New York Investor Event
Comprehensive review of broad pipeline targeting Alzheimer's disease agitation, depression, narcolepsy, fibromyalgia, ADHD, and smoking cessation, with new data analysesPresentations by expert clinicians and key opinion
07-21 19:37
